Work

A phase I trial of an anti-pka oligonucleotide (GEM231) administered with weekly CPT-11

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.2074

Authors: A. C. Lockhart, C. M. Rudin, J. D. Berlin, B. J. Roth, K. R. Hande, R. R. Martin, T. M. Sullivan, J. M. Grindel, R. Zhang, M. L. Rothenberg

Institutions: University of Alabama at Birmingham, University of Chicago, Vanderbilt University Medical Center

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W102123348

Cites:

Cited by:

Related to: 10